Aerobic glycolysis enables the effector differentiation potential of stem-like CD4 + T cells to combat cancer.

Autor: Zou D; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA., Zhang X; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA., Li S; Department of Cardiovascular Science, Houston Methodist Research Institute, Houston, TX, USA., Xiao X; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA., Gonzalez NM; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA., Minze LJ; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA., Li XC; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA.; Department of Surgery, Weill Cornell Medicine, Cornell University, New York, NY, USA., Chen W; Immunobiology & Transplant Science Center, Department of Surgery, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, USA. wchen@houstonmethodist.org.; Department of Surgery, Weill Cornell Medicine, Cornell University, New York, NY, USA. wchen@houstonmethodist.org.
Jazyk: angličtina
Zdroj: Cellular & molecular immunology [Cell Mol Immunol] 2024 May; Vol. 21 (5), pp. 527-529. Date of Electronic Publication: 2024 Mar 21.
DOI: 10.1038/s41423-024-01154-w
Databáze: MEDLINE